Business Restrictions and Compliance Costs Resulting from Tighter Chemical Substance Regulations
First written in FY2020. 11 of 13 entries say "Restated". Latest entry: FY2024.
Nof moved to the "Worse" side of this theme in 2024, 2 years after the typical company in this theme (2022).
The whole theme swung hardest in 2022: 4 of 8 companies on the "Worse" side.
0 other companies' latest entry also says "Reframed".
- FY2024ReframedAnnual report
「However, violations of various laws and regulations, including the Unfair Competition Prevention Act, Antimonopoly Act, Subcontract Act, Foreign Exchange and Foreign Trade Act, Chemical Substances Control Law and Pharmaceuticals and Medical Devices Act, may result in administrative sanctions, suspension of business activities, payment of surcharges and other consequences.」
The Company has shifted from its previous framework of presenting stricter chemical-substance regulations as a separate risk to a framework centered on the risk of violating laws and regulations, including the Chemical Substances Control Law and Pharmaceuticals and Medical Devices Act. - FY2024-Q2RestatedAnnual report
「During the six-month period ended [the current second quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The Company states that there has been no new occurrence or material change in the risk of business restrictions and increased compliance costs resulting from stricter chemical-substance regulations. - FY2024-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The risk of business restrictions and increased compliance costs resulting from stricter chemical-substance regulations is treated as involving no new occurrence or material change. - FY2023-Q3RestatedAnnual report
「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The risk of business restrictions and increased compliance costs resulting from stricter chemical-substance regulations is treated as involving no new occurrence or material change. - FY2023-Q2RestatedAnnual report
「During the six-month period ended [the current second quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The risk of business restrictions and increased compliance costs resulting from stricter chemical-substance regulations is treated as involving no new occurrence or material change. - FY2023-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The risk of business restrictions and increased compliance costs resulting from stricter chemical-substance regulations is treated as involving no new occurrence or material change. - FY2022-Q3RestatedAnnual report
「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The risk of business restrictions and increased compliance costs resulting from stricter chemical-substance regulations is treated as involving no new occurrence or material change. - FY2022-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The risk of business restrictions and increased compliance costs resulting from stricter chemical-substance regulations is treated as involving no new occurrence or material change. - FY2021RestatedAnnual report
「In particular, amid growing global awareness of the effects on the environment and health, regulations in Japan and overseas concerning the handling of chemical substances have generally been strengthened, and the Group is focusing on compliance with applicable laws and regulations. Changes in laws, regulations, policies and other requirements in the future may restrict business activities and increase compliance costs, potentially affecting the Group’s business performance and financial position.」
The Company continues to disclose the risk of business restrictions and increased compliance costs resulting from stricter chemical-substance regulations. - FY2021-Q3RestatedAnnual report
「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The risk of business restrictions and increased compliance costs resulting from stricter chemical-substance regulations is treated as involving no new occurrence or material change. - FY2021-Q2RestatedAnnual report
「During the six-month period ended [the current second quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The risk of business restrictions and increased compliance costs resulting from stricter chemical-substance regulations is treated as involving no new occurrence or material change. - FY2021-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The risk of business restrictions and increased compliance costs resulting from stricter chemical-substance regulations is treated as involving no new occurrence or material change. - FY2020First statedAnnual report
「Amid growing global awareness of the effects on the environment and health, regulations in Japan and overseas concerning the handling of chemical substances have generally been strengthened, and the Group is focusing on compliance with applicable laws and regulations. Changes in laws, regulations, policies and other requirements in the future may restrict business activities and increase compliance costs, potentially affecting the Group’s business performance and financial position.」
The Company organized the previous general regulatory risk into specific risks involving stricter chemical-substance regulations, business restrictions, and increased compliance costs.